Interleukin-1 Blockade In Recently Decompensated Heart Failure - 2
clinical trial
Press Enter · cited answer in seconds
0 sources
Summary
Interleukin-1 Blockade In Recently Decompensated Heart Failure - 2 is a clinical trial[1].
Key Facts
- Interleukin-1 Blockade In Recently Decompensated Heart Failure - 2 is in the country of United States[2].
- Interleukin-1 Blockade In Recently Decompensated Heart Failure - 2's instance of is recorded as clinical trial[3].
- Interleukin-1 Blockade In Recently Decompensated Heart Failure - 2's start time is recorded as +2019-01-04T00:00:00Z[4].
- Interleukin-1 Blockade In Recently Decompensated Heart Failure - 2's end time is recorded as +2023-06-30T00:00:00Z[5].
- Interleukin-1 Blockade In Recently Decompensated Heart Failure - 2's sponsor is recorded as Virginia Commonwealth University[6].
- Interleukin-1 Blockade In Recently Decompensated Heart Failure - 2's main subject is recorded as heart failure[7].
- Interleukin-1 Blockade In Recently Decompensated Heart Failure - 2's main subject is recorded as inflammation[8].
- Interleukin-1 Blockade In Recently Decompensated Heart Failure - 2's number of participants is recorded as {'unit': '1', 'amount': '+102'}[9].
- Interleukin-1 Blockade In Recently Decompensated Heart Failure - 2's title is recorded as The Effects of Interleukin-1 Blockade On Exercise Capacity In Patients With Recently Decompensated Systolic Heart Failure[10].
- Interleukin-1 Blockade In Recently Decompensated Heart Failure - 2's short name is recorded as REDHART2[11].
- Interleukin-1 Blockade In Recently Decompensated Heart Failure - 2's minimum age is recorded as {'unit': 'http://www.wikidata.org/entity/Q577', 'amount': '+21'}[12].
- Interleukin-1 Blockade In Recently Decompensated Heart Failure - 2's ClinicalTrials.gov ID is recorded as NCT03797001[13].
- Interleukin-1 Blockade In Recently Decompensated Heart Failure - 2's research intervention is recorded as anakinra[14].
- Interleukin-1 Blockade In Recently Decompensated Heart Failure - 2's clinical trial phase is recorded as phase II clinical trial[15].
- Interleukin-1 Blockade In Recently Decompensated Heart Failure - 2's research site is recorded as Virginia Commonwealth University[16].
- Interleukin-1 Blockade In Recently Decompensated Heart Failure - 2's study type is recorded as interventional study[17].